| 1. |
Chirakarnjanakorn S, Navaneethan SD, Francis GS, et al. Cardiovascular impact in patients undergoing maintenance hemodialysis: clinical management considerations. Int J Cardiol, 2017, 232: 12-23.
|
| 2. |
Feng Z, Wang X, Zhang L, et al. Pharmacokinetics and pharmacodynamics of sacubitril/valsartan in maintenance hemodialysis patients with heart failure. Blood Purif, 2022, 51(3): 270-279.
|
| 3. |
Ng CH, Ong ZH, Sran HK, et al. Comparison of cardiovascular mortality in hemodialysis versus peritoneal dialysis. Int Urol Nephrol, 2021, 53(7): 1363-1371.
|
| 4. |
Bramania PK, Ruggajo PJ, Furia FF. Prevalence and predictors of heart failure among patients on maintenance hemodialysis therapy at Muhimbili National Hospital in Tanzania: a cross-sectional study. Egypt Heart J, 2021, 73(1): 97.
|
| 5. |
Abdo AS. Diagnosis and Management of Heart Failure in Long-Term Dialysis Patients. Curr Heart Fail Rep, 2017, 14(5): 404-409.
|
| 6. |
Farah Yusuf Mohamud M, Nur Adan F, Osman Omar Jeele M, et al. Major cardiovascular events and associated factors among routine hemodialysis patients with end-stage renal disease at tertiary care hospital in Somalia. Front Med (Lausanne), 2023, 10: 1086359.
|
| 7. |
張敏. 綜合護理對尿毒癥患者血液透析期間合并心衰的預防效果. 世界最新醫學信息文摘, 2020, 20 (17): 230-231.
|
| 8. |
王晶, 劉宬博, 周亦倫, 等. 個體化健康管理對維持性血液透析患者水鈉控制依從性的影響. 中華護理雜志, 2016, 51(10): 1188-1192.
|
| 9. |
Zhang X, Tu B, Wan Z. Radial artery superficialization for hemodialysis patients with severe heart failure: a case report. Semin Dial, 2023, 36(3): 263-266.
|
| 10. |
白路. 評價綜合護理對尿毒癥患者血液透析期間合并心衰的效果. 自我保健, 2022(21): 215-216.
|
| 11. |
宮玉慧, 張家旺, 李俊智, 等. 精準健康管理模式在 2 型糖尿病中的應用研究進展. 中國保健營養, 2020, 30(15): 393.
|
| 12. |
Heyse A, Manhaeghe L, Mahieu E, et al. Sacubitril/valsartan in heart failure and end-stage renal insufficiency. ESC Heart Fail, 2019, 6(6): 1331-1333.
|
| 13. |
孫美蘭, 孫新, 楊麗. 維持性血液透析患者的精準飲食管理. 護理學雜志, 2022, 37(10): 20-22.
|
